Lifeboat Foundation

Scientists show the approach can kill cells that cause hardening of heart tissue in mice.

Ira Pastor, ideaXme longevity and aging ambassador and Founder of Bioquark, interviews Robin Farmanfarmaian, medical futurist, bestselling author, professional speaker, and CEO and Co-Founder of ArO.

Ira Pastor Comments:

Continue reading “Robin Farmanfarmaian’s Mission: To Empower The Healthcare Consumer” »

The future is now! 👌📸.

A new study of gravitational waves from merging black holes agrees with the predictions of the general theory of relativity.

NASA and SpaceX, the Emmy has landed.

In experiments in mice, Johns Hopkins Medicine researchers say they have developed a way to successfully transplant certain protective brain cells without the need for lifelong anti-rejection drugs.

A report on the research, published Sept. 16 in the journal Brain, details the new approach, which selectively circumvents the immune response against foreign cells, allowing transplanted cells to survive, thrive and protect brain tissue long after stopping immune-suppressing drugs.

The ability to successfully transplant healthy cells into the brain without the need for conventional anti-rejection drugs could advance the search for therapies that help children born with a rare but devastating class of genetic diseases in which myelin, the protective coating around neurons that helps them send messages, does not form normally. Approximately 1 of every 100,000 children born in the U.S. will have one of these diseases, such as Pelizaeus-Merzbacher disease. This disorder is characterized by infants missing developmental milestones such as sitting and walking, having involuntary muscle spasms, and potentially experiencing partial paralysis of the arms and legs, all caused by a genetic mutation in the genes that form myelin.

One year on, and the LEGO Technic Bugatti continues to amaze us! 🤩.

“And when you forget yourself, you see everything else”

-Jerry Garcia